Ruofei FENG

Dr. Ruofei FENG

northwest minzu university, Lanzhou, Gansu, China
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
YHYumei Han
Yumei Han
JXJingying Xie
Jingying Xie
SXShujuan Xu
Shujuan Xu
YBYingjie Bi
Yingjie Bi
XLXiangrong Li
Xiangrong Li
RFRuofei FENG
Ruofei FENG
Encephalomyocarditis virus is an important pathogen that can cause encephalitis, myocarditis, neurological diseases, and reproductive disorders. It also causes huge economic losses for the swine industry worldwide.

22 October 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
JXJingying Xie
Jingying Xie
XZXiangbo Zhang
Xiangbo Zhang
LCLei Chen
Lei Chen
YBYingjie Bi
Yingjie Bi
Adi IdrisAdi Idris
Adi Idris
RFRuofei FENG
Ruofei FENG
Pseudorabies virus is a typical swine alphaherpesvirus, which can cause obvious neurological disorders and reproductive failure in pigs. It is capable of evading host antiviral immune response. However, the mechanism by which many PRV proteins assist the virus to evade innate immunity is not fully understood. This study identified PRV US3 protein as a crucial antagonistic viral factor that represses interferon beta (IFN-β) expression. A in-depth study showed that US3 protein restricted type I IFN production by targeting interferon regulatory factor 3 (IRF3), a key molecule required for type I IFN induction. Additionally, US3 protein interacted with IRF3, degraded its protein expression to block the phosphorylation of IRF3. These findings suggested a novel strategy utilized by PRV to inhibit IFN-β production and escape the host innate immunity.

1 October 2020 in Virus Research
Verified
Journal Article
Closed access
JXJingying Xie
Jingying Xie
YBYingjie Bi
Yingjie Bi
SXShujuan Xu
Shujuan Xu
YHYumei Han
Yumei Han
Adi IdrisAdi Idris
Adi Idris
RFRuofei FENG
Ruofei FENG

30 March 2018 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
HZHaixia Zhang
Haixia Zhang
XWXinglong Wang
Xinglong Wang
XLXiangrong Li
Xiangrong Li
ZMZhongren Ma
Zhongren Ma
RFRuofei FENG
Ruofei FENG

28 March 2023 in Viruses
Verified
Journal Article
Open access
PDF file
LCLei Chen
Lei Chen
XLXiangrong Li
Xiangrong Li
YDYingying Deng
Yingying Deng
YBYingjie Bi
Yingjie Bi
ZYZhenfang Yan
Zhenfang Yan
RFRuofei FENG
Ruofei FENG
Interferon (IFN) helps cells fight viral infections by further inducing the expression of many downstream IFN-stimulated genes (ISGs). Human interferon-inducible transmembrane proteins (IFITM) are one of these ISGs. The antiviral function of human IFITM1, IFITM2, and IFITM3 are well known. In this study, we report that IFITM can significantly inhibit EMCV infectivity in HEK293 cells. Overexpression of IFITM proteins could promote IFN-β production. Meanwhile, IFITMs facilitated type I IFN signaling pathway adaptor MDA5 expression. We detected the binding of IFITM2 to MDA5 in a co-immunoprecipitation assay. It was also found that the ability of IFITM2 to activate IFN-β was significantly inhibited after interfering with MDA5 expression, suggesting that MDA5 may play an important role in the activation of the IFN-β signaling pathway by IFITM2. Moreover, the N-terminal domain plays an active role in the antiviral activity and the activation of IFN-β by IFITM2. These findings suggest that IFITM2 plays a vital role in antiviral signaling transduction. In addition, a positive feed-forward loop between IFITM2 and type I IFN establishes a key role for IFITM2 in enforcing innate immune responses.

7 March 2024 in Virology
Verified
Journal Article
Closed access
SLShasha Li
Shasha Li
HLHuixia Li
Huixia Li
RLRuiya Lian
Ruiya Lian
JXJingying Xie
Jingying Xie
RFRuofei FENG
Ruofei FENG